201 related articles for article (PubMed ID: 8642700)
1. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.
Porter DC; Melsen LR; Compans RW; Morrow CD
J Virol; 1996 Apr; 70(4):2643-9. PubMed ID: 8642700
[TBL] [Abstract][Full Text] [Related]
2. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.
Porter DC; Ansardi DC; Morrow CD
J Virol; 1995 Mar; 69(3):1548-55. PubMed ID: 7853488
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the expression and immunogenicity of poliovirus replicons that encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteins.
Anderson MJ; Porter DC; Moldoveanu Z; Fletcher TM; McPherson S; Morrow CD
AIDS Res Hum Retroviruses; 1997 Jan; 13(1):53-62. PubMed ID: 8989427
[TBL] [Abstract][Full Text] [Related]
4. Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase.
Ansardi DC; Pal-Ghosh R; Porter D; Morrow CD
J Virol; 1995 Feb; 69(2):1359-66. PubMed ID: 7815522
[TBL] [Abstract][Full Text] [Related]
5. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection.
Porter DC; Ansardi DC; Choi WS; Morrow CD
J Virol; 1993 Jul; 67(7):3712-9. PubMed ID: 8389902
[TBL] [Abstract][Full Text] [Related]
6. Poliovirus replicons that express the gag or the envelope surface protein of simian immunodeficiency virus SIV(smm) PBj14.
Anderson MJ; Porter DC; Fultz PN; Morrow CD
Virology; 1996 May; 219(1):140-9. PubMed ID: 8623523
[TBL] [Abstract][Full Text] [Related]
7. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins.
Moldoveanu Z; Porter DC; Lu A; McPherson S; Morrow CD
Vaccine; 1995 Aug; 13(11):1013-22. PubMed ID: 8525684
[TBL] [Abstract][Full Text] [Related]
8. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.
Ansardi DC; Porter DC; Morrow CD
J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418
[TBL] [Abstract][Full Text] [Related]
9. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.
Ansardi DC; Porter DC; Morrow CD
J Virol; 1993 Jun; 67(6):3684-90. PubMed ID: 8388519
[TBL] [Abstract][Full Text] [Related]
10. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.
Spearman P; Wang JJ; Vander Heyden N; Ratner L
J Virol; 1994 May; 68(5):3232-42. PubMed ID: 8151785
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.
Chazal N; Carrière C; Gay B; Boulanger P
J Virol; 1994 Jan; 68(1):111-22. PubMed ID: 8254720
[TBL] [Abstract][Full Text] [Related]
12. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.
Park J; Morrow CD
J Virol; 1992 Nov; 66(11):6304-13. PubMed ID: 1383561
[TBL] [Abstract][Full Text] [Related]
13. Characterization of poliovirus replicons encoding carcinoembryonic antigen.
Ansardi DC; Moldoveanu Z; Porter DC; Walker DE; Conry RM; LoBuglio AF; McPherson S; Morrow CD
Cancer Res; 1994 Dec; 54(24):6359-64. PubMed ID: 7527296
[TBL] [Abstract][Full Text] [Related]
14. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
Wagner R; Fliessbach H; Wanner G; Motz M; Niedrig M; Deby G; von Brunn A; Wolf H
Arch Virol; 1992; 127(1-4):117-37. PubMed ID: 1456888
[TBL] [Abstract][Full Text] [Related]
15. Construction and characterization of encapsidated poliovirus replicons that express biologically active murine interleukin-2.
Basak S; McPherson S; Kang S; Collawn JF; Morrow CD
J Interferon Cytokine Res; 1998 May; 18(5):305-13. PubMed ID: 9620357
[TBL] [Abstract][Full Text] [Related]
16. A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells.
Pal-Ghosh R; Morrow CD
J Virol; 1993 Aug; 67(8):4621-9. PubMed ID: 8392603
[TBL] [Abstract][Full Text] [Related]
17. Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells.
Royer M; Hong SS; Gay B; Cerutti M; Boulanger P
J Virol; 1992 May; 66(5):3230-5. PubMed ID: 1560545
[TBL] [Abstract][Full Text] [Related]
18. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
Ansardi DC; Morrow CD
J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
[TBL] [Abstract][Full Text] [Related]
19. Targeted foreign gene expression in spinal cord neurons using poliovirus replicons.
Bledsoe AW; Gillespie GY; Morrow CD
J Neurovirol; 2000 Apr; 6(2):95-105. PubMed ID: 10822323
[TBL] [Abstract][Full Text] [Related]
20. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.
McGettigan JP; Sarma S; Orenstein JM; Pomerantz RJ; Schnell MJ
J Virol; 2001 Sep; 75(18):8724-32. PubMed ID: 11507217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
